Sho Iketani, PhD

Research Project:
Developing Experimental Strategies for Large-Scale Studies of SARS-CoV-2

Grant Awarded:

Emerging Respiratory Pathogen Award

Research Topics:

basic biologic mechanisms
screening

Research Diseases:

COVID-19
respiratory viruses

COVID-19 remains an ongoing issue with continued illness and death. While we have gained significant understanding of the biology of the SARS-CoV-2 virus and have developed effective vaccines and therapeutics, there still remains much left unknown about the virus. One challenge in studying the virus has been the difficulty in running large-scale experiments of the virus itself. We will develop an approach that allows us to systematically study the functions of the virus’ proteins. While the data that we generate should be valuable for understanding SARS-CoV-2 and for developing new treatments against this virus, the methods that we build should be applicable to other viruses and diseases such as cancer. Therefore, although SARS-CoV-2 will be used as a model, our research has the potential to have a much wider impact.

Supported by the Mary Fuller Russell Fund

Page last updated: October 30, 2025

Join the Patient & Caregiver Network

How to Help People Quit

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Join a LUNG FORCE Walk

Double Your Gift

Sho Iketani, PhD

Your Gift = 2X the Impact

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA